WallStSmart
SGMT

Sagimet Biosciences Inc. Series A Common Stock

NASDAQ: SGMT · HEALTHCARE · BIOTECHNOLOGY

$7.71
+0.92% today

Updated 2026-05-08

Market cap
$476.11M
P/E ratio
P/S ratio
52.50x
EPS (TTM)
$-1.59
Dividend yield
52W range
$3 – $11
Volume
1.6M

Sagimet Biosciences Inc. Series A Common Stock (SGMT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+43.5%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+42.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-7.8%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-12.1%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-11$-0.29+27.8%$5.53$5.34-3.4%
2025-11-13$-0.40+61.5%$8.82$7.75-12.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.40$-0.29+27.8%
2025-09-30$-1.04$-0.40+61.5%
2025-06-30$-0.88$-0.32+63.6%
2025-03-31$-0.71$-0.56+21.1%
2024-12-31$-0.49$-0.50-2.0%
2024-09-30$-0.55$-0.45+18.2%
2024-06-30$-0.50$-0.25+50.0%
2024-03-31$-0.40$-0.23+42.5%
2023-12-31$-0.58$-0.78-34.5%
2023-09-30$-0.99$-0.35+64.6%$2.00M
2023-06-30$-0.50$-35.80-7060.0%
2023-03-31$0.00$-0.44

Frequently asked questions

Has Sagimet Biosciences Inc. Series A Common Stock beaten earnings estimates?
Sagimet Biosciences Inc. Series A Common Stock has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +43.5% over the last 4 quarters.
How does SGMT stock react to earnings?
SGMT stock has moved an average of -7.8% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.